Profiel
Dr. Leland Webster is Vice President-Business Development at Tetraphase Pharmaceuticals, Inc.
Dr. Webster was previously employed as Vice President-Corporate Development by Surface Logix, Inc., a Director-Business Development by ImmunoGen, Inc., and a Principal by Harvard University.
He also served on the board at Vertex Pharmaceuticals, Inc.
He received his undergraduate degree from Northwestern University, an MBA from the MIT Sloan School of Management, and a doctorate degree from the University of Pennsylvania.
Eerdere bekende functies van Leland Webster
| Bedrijven | Functie | Einde |
|---|---|---|
Surface Logix LLC
 Surface Logix LLC Pharmaceuticals: MajorHealth Technology Surface Logix LLC is a drug development company which involves biophysical chemistry to create new small molecule drugs. It creates chemical entities and focuses on cardiovascular and metabolic diseases. The company was founded by George M. Whitesides and Carmichael S. Roberts, Jr. and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01-01-2009 |
| TETRAPHASE PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
| VERTEX PHARMACEUTICALS INCORPORATED | Directeur/Bestuurslid | - |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
| IMMUNOGEN, INC. | Corporate Officer/Principal | - |
Opleiding van Leland Webster
| Northwestern University | Undergraduate Degree |
| University of Pennsylvania | Doctorate Degree |
| MIT Sloan School of Management | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
ImmunoGen, Inc.
 ImmunoGen, Inc. BiotechnologyHealth Technology ImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its pipeline includes Mirvetuximab Soravtansine, IMGN632, IMGC936, and IMGN151. The company was founded on March 27, 1981 and is headquartered in Waltham, MA. | Health Technology |
Tetraphase Pharmaceuticals, Inc.
 Tetraphase Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tetraphase Pharmaceuticals, Inc. is engaged in the development and production of novel tetracyclines for serious and life-threatening bacterial infections. It also develops eravacycline, a synthetic fluorocycline, as an intravenous and oral antibiotic for use as a first-line empiric monotherapy for the treatment of resistant and multi-drug-resistant infections. The company was founded on July 7, 2006 and is headquartered in Waltham, MA. | Health Technology |
Surface Logix LLC
Surface Logix LLC Pharmaceuticals: MajorHealth Technology Surface Logix LLC is a drug development company which involves biophysical chemistry to create new small molecule drugs. It creates chemical entities and focuses on cardiovascular and metabolic diseases. The company was founded by George M. Whitesides and Carmichael S. Roberts, Jr. and is headquartered in Cambridge, MA. | Health Technology |
